Teva Pharmaceutical Industries Limited (TEVA)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
$39.23+1.79%As of 2026-11-22 · USD
Last session low $38.30Last session high $39.91
52-week low $24.3452-week high $44.57
Market cap
$45.77B
Sector
Healthcare
P/E (TTM)
91.2x
Next earnings
2027-01-27 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)41.1In the neutral range (30 to 70)
MACD (12, 26, 9)0.17Below its signal line (0.62); histogram -0.45
Bollinger %B (20, 2)7%Inside the bands (38.80 to 44.68)
SMA 2041.74Price is 6.0% below
SMA 5040.62Price is 3.4% below
SMA 20035.25Price is 11.3% above
ATR (20)3.44% of priceAverage true range per day
52-week position74%In the upper part of the 24.34 to 44.57 range

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Insider filings, 90 daysNo purchases and 9 sales (about $32.9M).
Latest fiscal yearEnded 2025-12-31: revenue of $17.26B and an operating margin of 22.9%.
Next earnings reportExpected on 2027-01-27 (the date is an estimate).

More in Drug Manufacturers - Specialty & Generic